Blog
Article
This is a visual representation of an online publication from the American Society of Clinical Oncology 2023 Annual Meeting, June 2 - 6, 2023.
This is a visual representation of an online publication from the American Society of Clinical Oncology 2023 Annual Meeting, June 2 - 6, 2023.
David Penberthy1, Caroline Offit2, Christina Mangir3, Leigh Boehmer2, Bellinda King-Kallimanis4, Ramy Sedhom5, Cardinale B. Smith6, Smit Patel7, Jeffrey Kendall8, Jeff Hunnicutt9, Amanda G. Dean Martin10, Erin Pierce11, Anne Marie Rainey12, Adam P. Dicker13, Karen Fecenko-Tacka2
1Penn State Health, Hershey, PA; 2Association of Cancer Care Centers, Rockville, MD; 3Rhizome, LLC, Washington DC, DC; 4LUNGevity Foundation, Silver Spring, MD; 5Penn Medicine, Philadelphia, PA; 6Icahn School of Medicine at Mount Sinai, New York, NY; 7Digital Medicine Society, Boston, MA; 8University of Minnesota, Minneapolis, MN; 9Highlands Oncology Group, P.A., Fayetteville, AR; 10Banner MD Anderson Cancer Center, Gilbert, AZ; 11Ochsner Medical Center, New Orleans, LA; 12Clearview Cancer Institute, Huntsville, AL; 13Thomas Jefferson University Methodist Hospital, Philadelphia, PA
While the benefits and acceptability of remote patient monitoring (RPM) during cancer care are well documented, barriers to implementation and use of these digital technologies remain. Feasibility may be particularly restricted in rural settings. The Association of Cancer Care Centers (ACCC) surveyed U.S. cancer programs, patients with cancer and caregivers in various geographic settings to illuminate the current practice landscape and perceptions regarding the use of digital technologies to monitor patients for adverse events and collect patient reported outcomes (PROs).
See full abstract as well as a downloadable PDF in the Journal of Clinical Oncology (JCO).
See poster presented at the 2023 ASCO Annual Meeting. (You must sign in with your ASCO account username and password to access. Account set up is free.)
ACCC would like to thank our project partners: LUNGevity and Digital Medicine Society (DiMe).
This project is supported by AstraZeneca.